Wealthspire Advisors (Maryland)’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
$1.59M Sell
6,266
-4,234
-40% -$1.05M 0.06% 150
2020
Q2
$2.48M Buy
10,500
+976
+10% +$223K 0.18% 85
2020
Q1
$1.93M Sell
9,524
-160
-2% -$34.9K 0.17% 86
2019
Q4
$2.33M Sell
9,684
-449
-4% -$99K 0.16% 89
2019
Q3
$1.96M Buy
10,133
+1,695
+20% +$325K 0.14% 94
2019
Q2
$1.55M Sell
8,438
-219
-3% -$39.2K 0.12% 102
2019
Q1
$1.65M Buy
8,657
+638
+8% +$122K 0.12% 99
2018
Q4
$1.56M Buy
8,019
+604
+8% +$118K 0.14% 92
2018
Q3
$1.54M Sell
7,415
-595
-7% -$117K 0.13% 98
2018
Q2
$1.48M Buy
8,010
+341
+4% +$60.3K 0.13% 97
2018
Q1
$1.31M Buy
7,669
+588
+8% +$108K 0.12% 107
2017
Q4
$1.23M Buy
7,081
+992
+16% +$176K 0.12% 112
2017
Q3
$1.14M Buy
6,089
+1,092
+22% +$193K 0.12% 120
2017
Q2
$861K Buy
4,997
+737
+17% +$120K 0.1% 134
2017
Q1
$699K Sell
4,260
-106
-2% -$17.6K 0.1% 132
2016
Q4
$638K Sell
4,366
-934
-18% -$141K 0.1% 139
2016
Q3
$884K Buy
5,300
+166
+3% +$28.1K 0.14% 108
2016
Q2
$781K Buy
5,134
+352
+7% +$54.7K 0.13% 119
2016
Q1
$717K Buy
4,782
+181
+4% +$26.9K 0.13% 118
2015
Q4
$747K Buy
+4,601
New +$723K 0.14% 111

Other funds holding AMGN

Wealthspire Advisors (Maryland)'s AMGN Position: Q3 2020 in Review

Wealthspire Advisors (Maryland) reduced its Amgen (AMGN) stake by 40% in Q3 2020, selling an estimated $1.05M and leaving 6,266 shares worth $1.59M. The position accounts for 0.06% of the portfolio, ranked #150.

Wealthspire Advisors (Maryland) first reported a position in AMGN in Q4 2015 and has held it in 20 quarters since. The position peaked at $2.48M in Q2 2020. 2,127 funds tracked by Wall St. Rank hold AMGN as of Q3 2020.

  • Wealthspire Advisors (Maryland) held 6,266 shares of Amgen worth $1.59M as of Q3 2020.
  • Wealthspire Advisors (Maryland) sold 4,234 Amgen shares in Q3 2020, an estimated $1.05M.
  • Amgen made up 0.06% of Wealthspire Advisors (Maryland)'s portfolio in Q3 2020, its #150 holding.
  • Wealthspire Advisors (Maryland) first reported a position in Amgen in Q4 2015 and has held it in 20 quarters since.
  • Wealthspire Advisors (Maryland)'s Amgen position peaked at $2.48M in Q2 2020.
  • 2,127 funds tracked by Wall St. Rank held Amgen as of Q3 2020.

Based on Wealthspire Advisors (Maryland)'s 13F filing for Q3 2020, filed 13 Nov 2020.